Repurposing Anti-Cancer Drugs for COVID-19 Treatment
Author:
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference81 articles.
1. World Health Organization. Pneumonia of Unknown Cause - China; 2020.
2. Compassionate Use of Remdesivir for Patients with Severe Covid-19
3. Remdesivir for the Treatment of Covid-19 — Final Report
4. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
5. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chronic inflammation and cancer; the two sides of a coin;Life Sciences;2024-02
2. COVID‐19 and cancer: Dichotomy of the menacing dilemma;MedComm – Oncology;2023-11-30
3. Benzimidazole derivatives as tubulin polymerization inhibitors: Design, synthesis and in vitro cytotoxicity studies;Bioorganic & Medicinal Chemistry Letters;2023-11
4. A review on in silico virtual screening methods in COVID-19 using anticancer drugs and other natural/chemical inhibitors;Exploration of Targeted Anti-tumor Therapy;2023-10-26
5. Discovery of novel thiazole derivatives as anti‐breast cancer agents (MCF‐7) and validation of homologous effects on SARS‐CoV‐2 virus using in silico approaches;Vietnam Journal of Chemistry;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3